Tradition Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
60,161
+2,577
+4% +$441K 0.72% 38
2025
Q4
$9.72M Buy
57,584
+178
+0.3% +$28.9K 0.7% 38
2025
Q3
$8.29M Sell
57,406
-656
-1% -$89.5K 0.61% 42
2025
Q2
$7.35M Buy
58,062
+245
+0.4% +$30.1K 0.59% 44
2025
Q1
$7.39M Buy
57,817
+1,967
+4% +$267K 0.65% 42
2024
Q4
$7.38M Buy
55,850
+3
+0% +$422 0.65% 42
2024
Q3
$8.13M Buy
55,847
+1,790
+3% +$259K 0.72% 40
2024
Q2
$7.42M Buy
54,057
+2,273
+4% +$303K 0.72% 39
2024
Q1
$7.11M Sell
51,784
-1,016
-2% -$139K 0.72% 36
2023
Q4
$7.17M Buy
52,800
+3,537
+7% +$432K 0.75% 36
2023
Q3
$6.02M Buy
49,263
+1,630
+3% +$207K 0.72% 36
2023
Q2
$6.05M Buy
47,633
+1,467
+3% +$191K 0.71% 35
2023
Q1
$5.96M Buy
46,166
+2,219
+5% +$290K 0.74% 38
2022
Q4
$5.77M Buy
43,947
+684
+2% +$88.4K 0.81% 33
2022
Q3
$5.06M Sell
43,263
-2,083
-5% -$259K 0.76% 38
2022
Q2
$5.33M Buy
45,346
+2,725
+6% +$323K 0.77% 37
2022
Q1
$5.55M Buy
42,621
+6,730
+19% +$877K 0.71% 40
2021
Q4
$5.48M Buy
35,891
+6,836
+24% +$1.06M 0.69% 40
2021
Q3
$4.7M Buy
29,055
+1,742
+6% +$293K 0.67% 42
2021
Q2
$4.47M Buy
27,313
+2,804
+11% +$432K 0.67% 43
2021
Q1
$3.69M Buy
24,509
+10,356
+73% +$1.64M 0.64% 49
2020
Q4
$2.14M Buy
+14,153
New +$2.02M 0.42% 61

Other funds holding IBB

Tradition Wealth Management's IBB Position: Q1 2026 in Review

Tradition Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 4.5% in Q1 2026, buying an estimated $441K and bringing the position to 60,161 shares worth $10.2M. The position accounts for 0.72% of the portfolio, ranked #38.

Tradition Wealth Management first reported a position in IBB in Q4 2020 and has held it in 22 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Tradition Wealth Management held 60,161 shares of iShares Biotechnology ETF worth $10.2M as of Q1 2026.
  • Tradition Wealth Management bought 2,577 iShares Biotechnology ETF shares in Q1 2026, an estimated $441K.
  • iShares Biotechnology ETF made up 0.72% of Tradition Wealth Management's portfolio in Q1 2026, its #38 holding.
  • Tradition Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Tradition Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.